PRESS RELEASES

Moderna Covid-19 booster shot bolsters antibodies against variant strains

Editor May 6, 2021

Early results from trial show Moderna’s booster shot helps against variants of concern found in Brazil and South Africa Moderna’s Covid-19 booster shots gave positive results against immune system-evading strains that emerged in South Africa and Brazil, early results from a mid-stage

PRESS RELEASES

Moderna says protection from COVID-19 vaccine still strong after 6 months

Editor April 14, 2021

Study show efficacy of more than 90% for those receiving both doses New York: Moderna Inc said on Tuesday that its COVID-19 vaccine still showed strong protection against the illness six months after people received their second shot, with efficacy of more than 90 per cent against all cases and 95 per cent against severe cases. Read […]

Health

Alpho: The value of pharmaceutical companies will be affected by the resolution of production problems

Middle East News 247 March 4, 2021

Dubai, UAE: The vaccination marathon of the world’s population continues in 2021. Stocks of companies producing Covid-19 vaccines do not experience their all-time highs; they are in the same position as other sectors on financial markets. However, from the long-term perspective, production problems are expected to be resolved and ordered volumes are supposed to multiply

Health

Alpho: Problems with the delivery of vaccines correct stocks of pharmaceutical companies

Middle East News 247 January 31, 2021

Dubai, United Arab Emirates, 31 January 2021, (AETOSWire): After the enthusiasm in early January when logistics of vaccines against Covid-19 got underway and the stocks of pharmaceutical companies were growing, mid-January experienced correction of the stock prices. The negative news on the delay of the Pfizer and BioNTech vaccine caused the stocks of both companies […]

PRESS RELEASES

Severe reaction to Moderna vaccine ‘rare’: US study

Editor January 23, 2021 0

Anaphylaxis after receipt of Moderna COVID-19 vaccine appears to be a rare event Washington: Severe allergic reaction to Moderna’s COVID-19 vaccine is “rare,” US health authorities said Friday, with only 10 cases arising from more than four million first doses. The Centers for Disease Control and Prevention also emphasized that widespread vaccination was